Prevention and Management of Osteoradionecrosis in Patients With Head and Neck Cancer Treated With Radiation Therapy: ISOO-MASCC-ASCO Guideline Clinical Insights-Reference-Cited by-同舟云学术

Prevention and Management of Osteoradionecrosis in Patients With Head and Neck Cancer Treated With Radiation Therapy: ISOO-MASCC-ASCO Guideline Clinical Insights

Published:2024-05-01 Issue: Volume: Page:
ISSN:2688-1527
Container-title:JCO Oncology Practice
language:en
Short-container-title:JCO Oncol Pract

Author:

Saunders Deborah¹,Koyfman Shlomo A.²,Ismaila Nofisat³^ORCID,Futran Neal D.⁴,Mowery Yvonne M.⁵⁶^ORCID,Watson Erin⁷^ORCID,Yang David H.⁸^ORCID,Peterson Douglas E.⁹^ORCID

Affiliation:

1. Health Sciences North Research Institute, Northern Ontario School of Medicine, Health Sciences North, Sudbury, Ontario, Canada

2. Cleveland Clinic, Cleveland, OH

3. American Society of Clinical Oncology, Alexandria, VA

4. University of Washington School of Medicine, Seattle, WA

5. UPMC Hillman Cancer Center, Pittsburgh, PA

6. University of Pittsburgh, Pittsburgh, PA

7. Department of Dental Oncology, Princess Margaret Cancer Center/Faculty of Dentistry, University of Toronto, Toronto, Canada

8. BC Cancer/University of British Columbia, Vancouver, Canada

9. School of Dental Medicine, UConn Health, Farmington, CT

Publisher

American Society of Clinical Oncology (ASCO)

Link

https://ascopubs.org/doi/pdfdirect/10.1200/OP.24.00182

Reference14 articles.

1. Review of Osteoradionecrosis of the Jaw: Radiotherapy Modality, Technique, and Dose as Risk Factors

2. HOPON (Hyperbaric Oxygen for the Prevention of Osteoradionecrosis): A Randomized Controlled Trial of Hyperbaric Oxygen to Prevent Osteoradionecrosis of the Irradiated Mandible After Dentoalveolar Surgery

3. Is Adjunctive Hyperbaric Oxygen Treatment Alone or with Surgery the Proper Management for Active and Persistent Osteoradionecrosis?